跳转至内容
Merck
CN

CKT1MAG-97K

MILLIPLEX® Canine Kidney Toxicity Panel

Configurable Canine Kidney Toxicity Expanded 7-Plex Panel 1

登录 查看组织和合同定价。

关于此项目

UNSPSC Code:
12161503
NACRES:
NA.84
eCl@ss:
32161000
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

MILLIPLEX® Canine Kidney Toxicity Panel, Configurable Canine Kidney Toxicity Expanded 7-Plex Panel 1

species reactivity

canine

manufacturer/tradename

Milliplex®

Quality Level

packaging

1 ea of

assay range

accuracy: 89-107%
sensitivity: 0.005-0.630 ng/mL
(All other analytes; MinDC +2SD)

sensitivity: 0.670 pg/mL
(KIM-1; MinDC +2SD)

standard curve range: 0.01-10 ng/mL
(Cystatin C)

standard curve range: 0.01-10 ng/mL
(Osteopontin)

standard curve range: 0.03-20 ng/mL
(Lipocalin-2/NGAL)

standard curve range: 0.07-50 ng/mL
(IL-8)

standard curve range: 0.07-50 ng/mL
(MCP-1)

standard curve range: 1.0-700 pg/mL
(KIM-1)

standard curve range: 1.4-1,000 ng/mL
(Clusterin)

technique(s)

multiplexing: suitable

input

urine

detection method

fluorometric (Luminex® xMAP® technology)

shipped in

wet ice

storage temp.

2-8°C

General description

As one of the leading causes of drug candidate attrition, toxicity research is receiving more attention, especially in the search of sensitive, organ-specific toxicity biomarkers. In pharmaceutical and chemical industries, the kidney is routinely assessed during toxicity evaluations. The importance of the kidney as a central detoxification organ leads to a high exposure of renal tissue to drugs, reactive metabolites, and environmental compounds. Traditional markers for assessing renal toxicity, such as blood urea nitrogen (BUN) and serum creatinine, are insensitive and non-specific. For improved, non-invasive detection of acute nephrotoxicity, a panel of novel urinary kidney biomarkers has been identified and verified for preclinical studies in relevant animal species. The MILLIPLEX® portfolio provides a valuable research assay to investigate multiple biomarkers of kidney injury in canine urine samples using the Luminex® xMAP® instrument platform.

The MILLIPLEX® Canine Kidney Toxicity Expanded Panel 1 is to be used for the simultaneous quantification of the following 7 analytes in any combination in canine urine samples: Clusterin, Cystatin C, Kidney Injury Molecule-1 (KIM-1), IL-8, Lipocalin-2/NGAL, MCP-1, and Osteopontin (OPN). This kit uses a 96-well format, contains a lyophilized standard cocktail, two internal assay quality controls while can measure up to 38 samples in duplicate.

The Luminex® xMAP® platform uses a magnetic bead immunoassay format for ideal speed and sensitivity to quantitate multiple analytes simultaneously, dramatically improving productivity while conserving valuable sample volume.

Panel Type: Toxicity
Kidney injury in dogs involves complex inflammatory and cellular responses, reflected in biomarkers such as Clusterin, Cystatin C, IL-8 (CXCL8), KIM-1, MCP-1 (CCL2), NGAL (Lipocalin-2), and Osteopontin (OPN). Clusterin is a stress-induced protein linked to tissue protection and repair. Cystatin C reflects glomerular filtration efficiency. IL-8 and MCP-1 are chemokines involved in immune cell recruitment during inflammation. KIM-1 and NGAL are sensitive indicators of tubular damage, while OPN plays a role in fibrosis and immune modulation. Together, these analytes provide a comprehensive profile of renal injury, inflammation, and recovery in canine models

Other Notes

Sensitivity: See kit protocol for individual analytes sensitivities.

Legal Information

Luminex is a registered trademark of Luminex Corp
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp

Application

MILLIPLEX® Qualified assays undergo rigorous assay development, verification, and Quality Control testing to achieve optimal performance. Simultaneously analyze up to 7 analytes in canine urine samples.Analytes included: Clusterin, Cystatin C, IL-8 (CXCL8), KIM-1, MCP-1 (CCL2), NGAL (Lipocalin-2), Osteopontin (OPN)Assay Characteristics: Refer to assay protocol for details on cross-reactivity, sensitivity, precision, and accuracy.

Disclaimer

For research use only. Not for use in diagnostic procedures.Label License/Sticker for Assay Product:By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.
For research use only. Not for use in diagnostic procedures.Label License/Sticker for Assay Product:By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.
For research use only. Not for use in diagnostic procedures.Label License/Sticker for Assay Product:By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.

Features and Benefits

Features:
  • Targets key biomarkers of renal injury, inflammation, and tissue remodeling
  • Includes 7 analytes covering glomerular filtration, tubular damage, chemokine signaling, and fibrosis
  • Multiplex format enables simultaneous detection from minimal sample volume
  • Compatible with canine serum, plasma, and urine samples
  • Designed for kidney toxicity, nephropathy, and renal recovery research in dogs
Benefits:
  • Provides a detailed molecular profile of kidney damage and repair mechanisms
  • Supports evaluation of therapeutic interventions targeting renal inflammation and fibrosis
  • Facilitates monitoring of acute and chronic kidney injury in preclinical canine models
  • Enhances understanding of immune cell recruitment and tubular stress responses
  • Streamlines experimental workflows with high-throughput, multi-analyte capability

signalword

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2

target_organs

Respiratory Tract

存储类别

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

法规信息

新产品
此项目有

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Alvaro Felipe de Lima Ruy Dias et al.
Veterinary world, 13(8), 1620-1626 (2020-10-17)
Canine visceral leishmaniasis (CanL) has a broad spectrum of changes, with kidney disease being considered the main cause of mortality. Thus, this study aimed to monitor serum and urinary biomarkers in response to two short-term treatments for CanL. Thirty dogs

相关内容

Multiplex toxicity assays enable researchers to simultaneously measure multiple toxicity biomarkers of various organs to gain a better understanding of toxicity. Explore how MILLIPLEX® multiplex toxicity assays are advancing research on liver injury, kidney toxicity, genotoxicity, and more.

Discover benefits of using biomarker detection multiplex immunoassays for companion and agricultural animal health research and find vet med multiplex assays.

Novel kidney toxicity biomarkers expand options for acute nephrotoxicity detection. Multiplex assays measure multiple renal damage biomarkers in small sample volumes, minimizing time and costs. See how MILLIPLEX® multiplex kidney toxicity assays detected vancomycin-induced subacute nephrotoxicity in rat models.

Uncover tips and tricks to multiplexing in this guide from the experts. Learn how you can enhance the power of your research with MILLIPLEX® multiplexing, including industry guidance for immunoassays, multiplexing tips, one-day MILLIPLEX® multiplex assays for limited lab time, and more.

查看所有结果

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持